financetom
Business
financetom
/
Business
/
US CDC backs advisers' recommendation to pull broad support for COVID shot
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US CDC backs advisers' recommendation to pull broad support for COVID shot
Oct 6, 2025 8:33 AM

Oct 6 (Reuters) -

The U.S. Centers for Disease Control and Prevention on

Monday said it had adopted recommendations from a panel of

outside advisors without change, including that COVID-19

vaccines should be administered through shared decision-making

with a healthcare provider.

The new recommendation maintains access for the shot through

health insurance.

The recommendations come at a turbulent time for the CDC,

which recently saw the ouster of its former Director Susan

Monarez after resisting changes to vaccine policy advanced by

Health Secretary Robert F. Kennedy Jr.

The acting director of the CDC, Jim O'Neill, also signed

off on its advisers' recommendations against use of the combined

measles-mumps-rubella-varicella vaccine before the age of 4

years. Instead, separate shots will be given for

measles-mumps-rubella and varicella, commonly known as

chickenpox.

The immunization schedules will be updated on the CDC

website by Tuesday, the agency said.

Earlier this year, CDC said COVID vaccination in healthy

children aged 6 months to 17 years should follow shared clinical

decision by a child's parents and their healthcare provider,

after Kennedy said the recommendations for such children and

pregnant women would be dropped.

Kennedy, a long-time vaccine skeptic, has sought to rewrite

the country's immunization policies through a series of

far-reaching actions, including dismantling the national vaccine

advisory board and later reconstituting it with hand-picked

experts who share his opposition to COVID shots.

The U.S. Food and Drug Administration, in August, had

cleared updated COVID-19 vaccines for everyone over age 65 but

limited its approval for younger people to those with health

risks.

The three approved COVID shots are made by Pfizer ( PFE )

with German partner BioNTech, Moderna ( MRNA ), and

Novavax ( NVAX ) with Sanofi.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Saia CFO Douglas Col Planning to Retire
--Street Color: Saia CFO Douglas Col Planning to Retire
Apr 26, 2024
08:54 AM EDT, 04/26/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 469.00, Change: -74.02, Percent...
Anglo American Rejects BHP's 'Highly Unattractive' Bid, Sets Proposal Deadline For May 22
Anglo American Rejects BHP's 'Highly Unattractive' Bid, Sets Proposal Deadline For May 22
Apr 26, 2024
Anglo American rebuffed a $39-billion takeover proposal from BHP Group ( BHP ) , dismissing the offer as highly unattractive. What Happened: BHP’s bid, announced Thursday, April 25, involved an all-share offer. One of the conditions requires Anglo American to complete two separate demergers of its shareholdings in Anglo American Platinum (Amplats) and Kumba Iron Ore (Kumba). The Anglo American...
Toyota Motor Investing $1.4 Billion in Indiana Plant
Toyota Motor Investing $1.4 Billion in Indiana Plant
Apr 26, 2024
08:58 AM EDT, 04/26/2024 (MT Newswires) -- Toyota Motor ( TM ) said Thursday it plans to invest $1.4 billion in its Princeton, Indiana site to assemble three row battery electric SUV. The company's total investment in Indiana would reach to $8 billion, Toyota ( TM ) added. The investment will also add a new battery pack assembly line utilizing...
Exxon Mobil's Stock Slides Following Q1 Earnings - Here's Why
Exxon Mobil's Stock Slides Following Q1 Earnings - Here's Why
Apr 26, 2024
Exxon Mobil Corporation ( XOM ) shares are trading lower after the company reported first-quarter FY24 results.  Total revenues and other income stood at $83.083 billion, beating the consensus of $78.352 billion. Net production stood at 3,784 thousand oil-equivalent barrels per day, vs. 3,831 thousand oil-equivalent barrels per day in the prior-year quarter. Adjusted net profit came in at $8.22 billion, down from $11.62 billion a year ago due...
Copyright 2023-2026 - www.financetom.com All Rights Reserved